Literature DB >> 6381551

Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

S A Walker, T R Rogers, P G Riches, S White, J R Hobbs.   

Abstract

Serum C-reactive protein concentrations were measured serially during the early transplant period in 68 bone marrow recipients transplanted for leukaemia (34), chronic granulocytic leukaemia (2), severe aplastic anaemia (6), and various inborn errors of metabolism (26). There were 116 clearly documented episodes of infection or acute graft versus host disease or both. Serum C-reactive protein concentrations in patients with viral (11) or fungal infection (6) were normal or only slightly raised. In 32 patients with isolated acute graft versus host disease, only three (10%) showed serum C-reactive protein concentrations above 40 mg/l. Values greater than 40 mg/l were strongly suggestive of bacterial infections and values above 100 mg/l were seen only in patients (43) with bacterial infections with or without acute graft versus host disease. These findings suggest that serum C-reactive protein concentrations are valuable both for diagnosis and monitoring of such infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381551      PMCID: PMC498918          DOI: 10.1136/jcp.37.9.1018

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Infection complicating bone marrow transplantation: what are the risks and can they be reduced?

Authors:  T R Rogers
Journal:  J Hosp Infect       Date:  1982-06       Impact factor: 3.926

2.  C-reactive protein in rapid differentiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis: a preliminary report.

Authors:  H Peltola
Journal:  J Pediatr       Date:  1983-05       Impact factor: 4.406

Review 3.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 4.  C-reactive protein and the acute phase response.

Authors:  H Gewurz; C Mold; J Siegel; B Fiedel
Journal:  Adv Intern Med       Date:  1982

5.  Solid phase radioimmunoassays for human C-reactive protein.

Authors:  B Shine; F C de Beer; M B Pepys
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

6.  C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia.

Authors:  K P Schofield; F Voulgari; D I Gozzard; M J Leyland; N J Beeching; J Stuart
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

7.  C-reactive protein (CRP) in early diagnosis of neonatal septicemia.

Authors:  K G Sabel; C Wadsworth
Journal:  Acta Paediatr Scand       Date:  1979-11

8.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

Authors:  R Storb; R L Prentice; C D Buckner; R A Clift; F Appelbaum; J Deeg; K Doney; J A Hansen; M Mason; J E Sanders; J Singer; K M Sullivan; R P Witherspoon; E D Thomas
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

9.  Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.

Authors:  A J Barrett; J R Kendra; C F Lucas; D V Joss; R Joshi; P Pendharkar; K Hugh-Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-17

10.  Response of graft versus host disease to high doses of methyl prednisolone.

Authors:  J Kendra; A J Barrett; C Lucas; R Joshi; V Joss; M Desai; O Halil; T R Rogers; J R Hobbs; K Hugh-Jones
Journal:  Clin Lab Haematol       Date:  1981
View more
  9 in total

1.  Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

Authors:  M Uguccioni; R Meliconi; E Lalli; S Nesci; C Delfini; G Lucarelli; G Gasbarrini; A Facchini
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation.

Authors:  R E Chambers; C W Hutton; P A Dieppe; J T Whicher
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

3.  C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation.

Authors:  C de Bel; E Gerritsen; G de Maaker; A Moolenaar; J Vossen
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

4.  Changes in plasma fibronectin during allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M Bowen
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

5.  The effects of pretransplant conditioning, graft-versus-host disease and sepsis on the CRP levels in bone marrow transplantation.

Authors:  E Rintala; K Remes; T T Salmi; P Koskinen; J Nikoskelainen
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

6.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period.

Authors:  S A Walker; P G Riches; T R Rogers; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

7.  Antithrombin III in the diagnosis of infection in febrile neutropenic patients.

Authors:  C C Kibbler; H G Prentice; P Noone
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Changes in plasma beta 2 microglobulin concentrations after allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M A Forbes; E H Cooper; J A Child
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

9.  Serial study of C reactive protein concentrations in cardiac allograft recipients.

Authors:  G D Harkiss
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.